Clinical trial
Evaluating Silymarin for Chronic Hepatitis C
NCT00030030 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00030030 |
|---|---|
| Title | Evaluating Silymarin for Chronic Hepatitis C |
| Official title | Evaluating Silymarin for Chronic Hepatitis C |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Collaborators | Office of Dietary Supplements (ODS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | Silymarin (milk thistle) |
| Start date | Jul 1, 2000 |
| Completion | Jun 1, 2002 |
| First posted | Jan 31, 2002 |
| Last update posted | Aug 18, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: